GT Biopharma, Inc. Business Finance Contracts & Agreements

113 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Prefunded Common Stock Purchase Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Series B Inducement Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Series A Inducement Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Placement Agent Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Pre-Funded Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Common Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Form of Securities Purchase Agreement, dated May 21, 2024
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2024
Form of Common Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2023
Form of Placement Agent Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Form of Pre-Funded Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Certificate of Designation of Preferences, Rights and Limitations of Series K Preferred Stock of GT Biopharma, Inc., dated April 3, 2019
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of December 2020 / January 2021 Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note, effective as of January 31, 2021, by and between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of December 2020 / January 2021 Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Securities Purchase Agreement - December 2020 / January 2021 Notes
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Settlement Note with Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of Underwriting Agreement
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Pre-Funded Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Warrant
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Form of Amendment to Convertible Note, dated as of January 31, 2021
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
Form of Second Amendment and Extension of Standstill and Forbearance Agreement
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
2021
CONVERTIBLE NOTE DUE JANUARY 31, 2021
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
AMENDMENT TO CONVERTIBLE NOTE & STANDSTILLAGREEMENT
Note Agreements
GT Biopharma, Inc.
Biotechnology
2020
Form of Settlement Note, dated November 9, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Registration Rights Agreement
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Secured Convertible Note
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
STANDSTILL AND FORBEARANCE AGREEMENT
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Pre-Funded Warrant to Purchase Common Stock, dated June 19, 2020 (included in Exhibit 10.1)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Convertible Note, dated June 19, 2020 (included in Exhibit 10.1)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Note, dated April/May, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Form of Registration Rights Agreement by and among the Company and the Buyers, dated April/May, 2020
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020